SHIONOGI & CO., LTD. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7,146 JPY | +1.51% |
|
+3.27% | +5.13% |
| May. 14 | Japan's Nikkei drifts sideways as more earnings, US CPI awaited | RE |
| May. 13 | Japan's Shionogi says COVID treatment did not meet endpoint in late-stage trial | RE |
Shionogi & Co., Ltd. specializes in development, manufacturing and marketing of pharmaceutical products. The group's activity is organized around 3 families of products:
- prescription products: drugs for the treatment of cardiovascular and infectious diseases, diabetes, allergic reactions, etc.;
- OTC products: analgesic products, vitamins and tonics, etc.;
- diagnosis products: primarily for detection and treatment of cardiovascular diseases and immune system.
Sector
Pharmaceuticals
Calendar
2024-06-06
- R&D Day
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
7,040
JPY
Average target price
7,967
JPY
Spread / Average Target
+13.17%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +5.13% | 12.69B | |
| +40.73% | 739B | |
| +32.83% | 598B | |
| -6.30% | 353B | |
| +15.15% | 318B | |
| +4.05% | 285B | |
| +15.00% | 240B | |
| +9.78% | 210B | |
| -5.52% | 206B | |
| +6.17% | 164B |
- Stock Market
- Equities
- 4507 Stock
- Funds and ETFs Shionogi & Co., Ltd.
